SII manufactured BCG vaccine gets export nod to treat bladder cancer
The Serum Institute of India has been granted permission to export its BCG vaccine to Canada for the treatment of bladder cancer, following a request from the director, Prakash Kumar Singh. BCG as immunotherapy is a live freeze-dried preparation derived from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin) and is sold in 40mg and 80mg presentations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 24, 2023 Category: Pharmaceuticals Source Type: news
TB vaccine candidate to enter final trial, raising hopes of saving millions
If the next steps are successful, M72 would be the first new vaccine in a century to target tuberculosis, a disease that killed 1.6 million people in 2021. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 30, 2023 Category: Consumer Health News Authors: Shera Avi-Yonah Source Type: news
Tuberculosis vaccine to enter final trials, raising hopes of saving millions
If the next steps are successful, M72 would be the first new vaccine in a century to target tuberculosis, a disease that killed 1.6 million people in 2021. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 30, 2023 Category: Consumer Health News Authors: Shera Avi-Yonah Source Type: news
South Africa: Funding Secured for Massive TB Vaccine Trial
[spotlight] A massive and much-anticipated phase 3 trial of an experimental tuberculosis (TB) vaccine is set to proceed after funding for it has been secured from two large philanthropies. Wellcome and the Bill & Melinda Gates Foundation (BMGF) Wednesday announced they'd be investing a combined $550 million into the trial - around $150 million from Wellcome and the remaining from the Bill & Melinda Gates Medical Research Institute, a nonprofit subsidiary of the BMGF. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - June 29, 2023 Category: Infectious Diseases Tags: Health and Medicine NGOs and Civil Society South Africa Southern Africa Tuberculosis Source Type: news
Africa: Wellcome and Gates Foundation to Fund Late-Stage Development of TB Vaccine Candidate That Could Be First in 100 Years If Proven Effective
[Gates Foundation] London and Seattle -- TB is one of the world's deadliest diseases, killing about 4,300 people per day, mostly those living in povert (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - June 29, 2023 Category: Infectious Diseases Tags: Africa External Relations Health and Medicine International Organizations and Africa Tuberculosis Source Type: news
South Africa: South Africa Included in Gates-Led Clinical Trial of New TB Vaccine Hailed As Potential Game-Changer
[Daily Maverick] A Phase 3 clinical trial for M72, a new candidate vaccine against pulmonary tuberculosis will be conducted in South Africa. The head of Global Health at the Bill & Melinda Gates Foundation, Dr Trevor Mundel, said this week that they were very optimistic that it would be an effective and safe vaccine. However, this will be determined by the success of the Phase 3 trials. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - June 29, 2023 Category: Infectious Diseases Tags: External Relations Health and Medicine International Organizations and Africa South Africa Southern Africa Tuberculosis Source Type: news
Wellcome Trust, Gates Foundation Fund First New TB Vaccine in 100 Years
The last time the TB vaccine had an update Warren Harding was president. For the first time in over a century, a new tuberculosis vaccine is entering large-scale critical trials, courtesy of a more than half-billion dollar contribution from two of the world’s leading medical charities: The Bill &…#tb #warrenharding #wellcometrust #gatesfoundations #m72 #africa #southeastasia #gatesfoundation #wellcome #offshelfits (Source: Reuters: Health)
Source: Reuters: Health - June 29, 2023 Category: Consumer Health News Source Type: news
Gates Foundation and Wellcome fund $550mn trial of first new TB vaccine for 100 years
Large-scale study will test GSK’s jab in 26,000 people in Africa and south-east Asia (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 28, 2023 Category: Pharmaceuticals Source Type: news
Bladder Cancer Treatment May Lower Risk for Alzheimer and Related Dementias
MONDAY, June 12, 2023 -- The bacillus Calmette-Guerin (BCG) vaccine is associated with a significantly lower rate and risk for Alzheimer disease and related dementias (ADRD) among patients with bladder cancer, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 12, 2023 Category: Pharmaceuticals Source Type: news
BCG Vaccine Does Not Reduce COVID-19 Risk for Health Care Workers
THURSDAY, April 27, 2023 -- The bacille Calmette-Guérin (BCG) vaccine does not result in lower risk for COVID-19 for health care workers, according to a study published in the April 27 issue of the New England Journal of Medicine.
Laure F.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2023 Category: Pharmaceuticals Source Type: news
BCG Vaccine Flops Again for COVID-19 Prevention
(MedPage Today) -- Another large randomized trial testing a bacillus Calmette-Guérin (BCG) vaccine as a means of thwarting COVID-19 failed to show any benefit, researchers reported.
In the multinational BRACE study, healthcare workers were... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - April 26, 2023 Category: Infectious Diseases Source Type: news
Century-Old TB Vaccine Fails to Protect Against Covid
Early in the pandemic, scientists began testing an old TB vaccine against the coronavirus. But the trial enrolled fewer participants than expected as new Covid vaccines were introduced, and no discernible effect was found. (Source: NYT Health)
Source: NYT Health - April 26, 2023 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Coronavirus (2019-nCoV) Vaccination and Immunization Immune System Tuberculosis Clinical Trials New England Journal of Medicine Source Type: news
Temperature-stable TB vaccine is safe and provokes immune response
An experimental tuberculosis vaccine that can be stored at room temperature was safe and provoked an immune response in a Phase 1 clinical trial. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - March 13, 2023 Category: Consumer Health News Source Type: news
Breakthrough For Tuberculosis —One Of The World’s Biggest Killers—As New Vaccine Shows Promise In Early Trials
Researchers on Monday announced promising results for a tuberculosis vaccine that can be freeze-dried and safely stored at higher temperatures for months, hailing a major breakthrough in the fight against one of humanity ’s biggest killers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 6, 2023 Category: Pharmaceuticals Tags: Business /business Healthcare /healthcare Source Type: news
Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported Study
Freeze-dried experimental TB vaccine tested in healthy adults. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - March 6, 2023 Category: American Health Source Type: news
